Vincerx Pharma, Inc. Deferred Tax Liabilities, Net
Vincerx Pharma, Inc. had Deferred Tax Liabilities, Net of $0 as of 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net
us-gaap:DeferredTaxLiabilities · last filed 2025-03-27
- 2024-12-31: Deferred Tax Liabilities, Net $0.00.
- 2023-12-31: Deferred Tax Liabilities, Net $526.00K.
- 2022-12-31: Deferred Tax Liabilities, Net $644.00K.
- 2021-12-31: Deferred Tax Liabilities, Net $829.00K.
| Period end | Deferred Tax Liabilities, Net |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-27 |
| 2023-12-31 | $526.00K 10-K · filed 2025-03-27 |
| 2022-12-31 | $644.00K 10-K · filed 2024-03-29 |
| 2021-12-31 | $829.00K 10-K · filed 2023-03-28 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-29 |